We are pleased to announce that ScanDroitin® has been approved as an Individually Recognized Functional Ingredient by the Ministry of Food and Drug Safety (MFDS) in South Korea.
The approval has ben obtained by our Korean partner, Daehan Chemtech Co., Ltd., and represents an important regulatory milestone for ScanDroitin® in the Korean market.
MFDS recognition confirms that ScanDroitin® meets the relevant requirements for safety, quality, and functional ingredient evaluation under the Korean regulatory framework. This achievement reflects the strong scientific foundation and quality standards underlying the ScanDroitin® brand.
We are proud of this collaboration and look forward to introducing chondroitin sulfate to the South Korean market together with our partners.
